1h Free Analyst Time
OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi-drug resistant organisms (MDROs). OpGen develops products that include AREScloud, ARESd, Unyvero LRT Panels, Unyvero Urinary Tract Infection (UTI) Panel, Unyvero System, SARS-CoV-2 test kit, Acuitas molecular diagnostic and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.OpGen Inc Key Recent Developments
- Aug 03, 2023: OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th
- Jun 26, 2023: Opgen Subsidiary Ares Genetics Successfully Maintains Key Patent Under Opposition in Europe
- May 15, 2023: OpGen reports Q1 2023 financial results and provides business update
- May 08, 2023: OpGen to provide business update and financial results for the first quarter 2023 on May 15th at 4:30 p.m. eastern time
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- GenMark Diagnostics Inc
- Becton Dickinson and Co
- Eurofins Genomics GmbH
- Cepheid Inc
- bioMerieux SA
- Laboratory Corp of America Holdings
- Accelerate Diagnostics Inc
- Pathnostics
- T2 Biosystems Inc
- Quest Diagnostics Inc
- GenMark Diagnostics Inc
- AutoGenomics Inc
- Cepheid Inc
- bioMerieux SA
- Becton Dickinson and Co
- Laboratory Corp of America Holdings
- Pathnostics
- T2 Biosystems Inc
- ARUP Laboratories
- Accelerate Diagnostics Inc
- Quest Diagnostics Inc
- Eurofins Genomics GmbH